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Metabolic reprogramming during macrophage polarization supports the effector
functions of these cells in health and disease. Here, we demonstrate that pyruvate
dehydrogenase kinase (PDK), which inhibits the pyruvate dehydrogenase-mediated
conversion of cytosolic pyruvate to mitochondrial acetyl-CoA, functions as a metabolic
checkpoint in M1 macrophages. Polarization was not prevented by PDK2 or PDK4
deletion but was fully prevented by the combined deletion of PDK2 and PDK4; this
lack of polarization was correlated with improved mitochondrial respiration and rewiring
of metabolic breaks that are characterized by increased glycolytic intermediates and
reduced metabolites in the TCA cycle. Genetic deletion or pharmacological inhibition
of PDK2/4 prevents polarization of macrophages to the M1 phenotype in response to
inflammatory stimuli (lipopolysaccharide plus IFN-γ). Transplantation of PDK2/4-deficient
bone marrow into irradiated wild-type mice to produce mice with PDK2/4-deficient
myeloid cells prevented M1 polarization, reduced obesity-associated insulin resistance,
and ameliorated adipose tissue inflammation. A novel, pharmacological PDK inhibitor,
KPLH1130, improved high-fat diet-induced insulin resistance; this was correlated with a
reduction in the levels of pro-inflammatory markers and improved mitochondrial function.
These studies identify PDK2/4 as a metabolic checkpoint for M1 phenotype polarization
of macrophages, which could potentially be exploited as a novel therapeutic target for
obesity-associated metabolic disorders and other inflammatory conditions.
Keywords: dichloroacetate, high-fat diet, inflammation, insulin resistance, macrophage polarization, metabolic
reprogramming, pyruvate dehydrogenase kinase
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INTRODUCTION
Macrophage polarization (M1/M2) requires metabolic
reprogramming that enhances glycolysis and repurposes
mitochondrial function (1–3). Although the importance of these
metabolic pathway differences betweenM1 andM2macrophages
is well-established, our knowledge of the checkpoints in affected
metabolic pathways is limited primarily to HIF-1α and pyruvate
kinase M2 (PKM2) (4). Obesity-induced insulin resistance
is a disease process in which M1 macrophages contribute to
adipose tissue (AT) inflammation and insulin resistance. Chronic
low-grade inflammation in multiple organs increases the risk
of developing obesity, diabetes, cardiovascular diseases, and
cancers, indicating a major role for the immune system in
the etiology of metabolic disorders (5). Recruitment of M1
macrophages, IFN-γ-secreting Th1 cells, CD8+ T cells, and B
cells in the adipose tissue drives the inflammatory response,
locally promoting systemic inflammation and impaired insulin
action as a result of over-nutrition (6, 7). The phenotypic changes
in macrophages that occur in response to over consumption of
energy are considered potential therapeutic targets for managing
chronic metabolic diseases.
Pyruvate dehydrogenase kinase (PDK) provides a therapeutic
target for the Warburg effect in malignant cancers (8) and has
been suggested to serve this function during macrophage
polarization (9). PDK1 participates in M1 macrophage
polarization via HIF-1α-mediated aerobic glycolysis, accounting
for the proinflammatory responses (9). In contrast, among the
four PDK isozymes, PDK2 and PDK4 are the most strongly
associated with metabolic diseases, especially type 2-diabetes
(10). Recent work from our laboratory has indicated that dual
deficiency of Pdk2 and Pdk4 (PDK2/4 DKO) attenuates the
lactic acid surge, the proinflammatory markers, and the pain
hypersensitivity suggesting a key role for the PDK-PDH-lactic
acid axis in the pathogenesis of inflammatory pain mediated by
macrophage functional regulation (11). This finding suggests a
novel therapeutic approach for many inflammatory conditions
but is seemingly at odds with conclusions of others who have
addressed the role of the PDKs in macrophage polarization
(12–14); we have, therefore, examined this phenomenon in
greater depth in the present study.
Here we provide additional evidence for PDK4 induction
in macrophages in response to LPS and IFN-γ. We also show
that genetic and pharmacological blockage of PDK activity
in mice fed a high-fat diet (HFD) represses macrophage M1
polarization, which is correlated with amelioration of adipose
tissue inflammation as well as insulin resistance. These findings
support the hypothesis that the PDKs are therapeutic targets for
inflammatory diseases.
MATERIALS AND METHODS
Animals
All experiments were approved by the Institutional Animal Care
and Use Committee of Kyungpook National University and
were conducted according to recommendations in the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. Eight-week-old male WT (C57BL/6J) and PDK2/4
DKOmice (15) were either fed a HFD 20% of the calories derived
from carbohydrates and 60% from fat (Research Diets; D12492
pellets) for use as a diet-induced obesity (DIO) model or fed an
isocaloric control diet (CD) in which 70% of the calories were
derived from carbohydrates and 10% from fat (Research Diets;
D12450B pellets). The mice were housed and maintained on a
12 h light/dark cycle at 22 ± 2◦C. After the mice were sacrificed,
the tissues were rapidly collected and freeze-clamped with liquid
nitrogen-cooled Wollenberger tongs and stored at −80◦C prior
to analysis.
Isolation of Peritoneal Macrophages (PMs)
Eight- to ten-week-old WT, PDK2 KO (2KO), PDK4 KO
(4KO), and PDK2/4 DKO mice (15–17) were injected with
3% thioglycollate broth, i.p., and then sacrificed 4 days later.
Peritoneal lavage was performed twice using 4mL of 1X PBS,
and the harvested cells were then cultured in RPMI1640 (Gibco;
11875-093) supplemented with antibiotics. After 1 h of culture,
the suspended cells were discarded, and the adherent cells were
used for experiments.
Isolation and Differentiation of Bone
Marrow-Derived Macrophages (BMDMs)
Bone marrow cells were collected from the femurs and tibias
of 8- to 10-week-old mice. The cells were cultured at 2 ×
107 cells/plate in α-MEM medium (WELGENE; LM 008-02)
containing 30% L929-conditioned media and 10% FBS for 9 days
to allow the differentiation. The established BMDMs were then
used for experiments.
Isolation of Peritoneal Macrophages (PMs)
by Zymosan a or LPS Treatment
Zymosan-elicited peritoneal macrophages (ZEPMs) and LPS-
elicited peritoneal macrophages (LEPMs) were isolated as
previously reported (18). Briefly, zymosan A (1 mg/mouse) or
LPS (1 mg/kg) were i.p. injected into 8-week-old C57BL/6J mice.
One day after the injection, peritoneal fluid was harvested and
cells were cultured in RPMI1640 supplemented with antibiotics.
After 1 h of culture, the suspended cells were discarded and the
adherent cells were used for experiments.
Western Blot Analysis
The tissue cells were lysed using a lysis buffer [20mM Tris
(pH 7.4), 10mM Na4P2OH, 100mM NaF, 2mM Na3VO4, 5mM
EDTA (pH 8.0), 0.1mM PMSF, and 1% NP-40] containing
protease inhibitors (aprotinin 7µg/mL and leupeptin 7µg/mL)
and phosphatase inhibitor cocktail. Protein concentrations were
measured using BCA protein assay reagent (Thermo Fisher
Scientific; 23225). Cell lysates were separated on 10% SDS-
polyacrylamide gels and then transferred to polyvinylidene
difluoride membranes (Merck Millipore; IPVH00010). The
transferred proteins on the membrane were immunoblotted with
the following primary antibodies: anti-HIF-1α (1:1,000), anti-
iNOS (1:1,000), anti-Arg-1 (1:1,000), anti-PDK2 (1:1,000), anti-
PDK4 (1:500), and anti-β-actin (1:5,000). All antibodies were
diluted in TBST containing 5% BSA.
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Measurement of Oxygen Consumption
Rate (OCR)
The OCR was measured using a Seahorse XF-24 Flux Analyzer
(Seahorse Biosciences, Billerica, MA, USA). BMDMswere seeded
in XF-24 tissue culture plates (24-well) at a density of 1 ×
105 cells/well and incubated overnight. The cells were treated
with M1 stimulants (LPS 100 ng/mL + IFN-γ 10 ng/mL) with
or without dichloroacetate (DCA 10mM, Sigma; 47795) for
3 h. The assay medium used consisted of XF base medium
(Seahorse Biosciences) supplemented with 5.5mM D-glucose
(Sigma-Aldrich; G7528), 1mM sodium pyruvate (Sigma-Aldrich;
S8636), and 1X GlutaMAXTM (Gibco; 35050) and adjusted to
pH 7.4. The inhibitors and uncouplers used in this study
were as follows: oligomycin A (2µM, Sigma-Aldrich; 75351),
CCCP (carbonyl cyanide 3-chlorophenylhydrazone, 7.5µM,
Sigma-Aldrich; C2759), rotenone (1µM, Sigma-Aldrich; R8875),
and antimycin A (2.5µM, Sigma-Aldrich; A8674). OCR was
normalized to protein concentration.
Metabolite Extraction
Isolated cells were cultured overnight in 10% dialyzed FBSmedia.
The medium was replaced with fresh 10% dialyzed FBS medium
and cells were then stimulated with LPS (100 ng/mL) and IFN-γ
(10 ng/mL) for 12 h. Cells were washed with 3mL ice-cold 0.9%
NaCl twice and then collected in Eppendorf tubes. Cells were
resuspended in 200 µL of ice-cold metabolite extraction solution
(chloroform:methanol:water 1:3:1, v/v) and then sonicated. After
incubation on ice for 1 h, the metabolite samples were collected
by centrifugation at 13,000 rpm for 5min. All the samples were
lyophilized and re-suspended in 300µL of water containing 0.1%
formic acid, prior to LC-MS/MS analysis.
Data Presentation and Statistical Analysis
Data were presented using the GraphPad Prism software and
statistical analysis was performed using IBM SPSS Statistics
(version 21). Statistically significant differences were measured
by Student’s t-test for normally distributed data. Statistical
analysis of group comparison was performed by one-way or
two-way ANOVA followed by Tukey’s HSD (honestly significant
difference) post hoc test. p-values < 0.05 were considered
statistically significant. Detailed procedures are included as part
of Supplemental Materials.
Detailed Procedures
See the Supplemental Materials.
RESULTS
PDK2 and PDK4 Are Required for M1
Macrophage Polarization
We explored the role of PDKs in overnutrition-induced AT
inflammation. Among the 4 different isoforms of PDK, the
mRNA expression of only Pdk4 was significantly upregulated
in the AT of mice fed an HFD compared to those fed a CD
(Figure 1A). Furthermore, Pdk4 was more responsive to specific
M1 stimulation, which was correlated with the upregulation of
Pdk4, and M2 stimulation, correlated with pdk4 downregulation
in macrophages (Figures 1A,B and Figures S1A–D). The
induction of HIF-1α and iNOS by M1-only stimulation and
M1+M2 stimulation, respectively, to mimic in vivo wild-
type (WT) conditions, was completely suppressed in PDK2/4
DKO mice but only slightly suppressed in PDK2 or PDK4
KO-peritoneal macrophages (PMs) and bone marrow-derived
macrophages (BMDMs) (Figure 1C), suggesting that PDK2
and PDK4 can functionally compensate for each other. And
we confirmed no change of PDK1 expression in DKO mice
(Figure 1D and Figures S1E,F). Conversely,M2 stimulation with
IL-4 caused a greater increase in arginase-1 expression in a time-
dependent manner in PMs from PDK2/4 DKOmice compared to
those from WT mice (Figure S1G). Since HIF-1α is essential for
the upregulation of glycolytic genes and, therefore, the activation
of inflammatory macrophages, suppression of the increase in
HIF-1α by PDK2/4 deficiency in response to LPS + IFN-γ
stimulation is especially noteworthy.
RNA-seq analysis revealed increased aerobic glycolysis in
response to M1 stimulation; this was indicated by increased
expression of glycolysis-related genes and decreased expression
of TCA cycle-related genes. This response was practically
absent in LPS + IFN-γ-stimulated PMs from PDK2/4 DKO
mice (Figures 1E–G). Consistently, the decrease in isocitrate
dehydrogenase (Idh)1 and Idh2 mRNA expression levels that
normally occur in response to LPS + IFN-γ stimulation
was prevented (Figure 1F). The expression of Irg1 required
for the production of itaconic acid, an important factor in
the antimicrobial response of macrophages was less affected,
yet significantly suppressed in the PMs from PDK2/4 DKO
mice (Figure 1F). To evaluate the mitochondrial function in
response to reduced PDK activity, we measured the oxygen
consumption rate (OCR) in both PDK2/4-deficient BMDMs and
dichloroacetate (DCA; pan PDK inhibitor)-treated BMDMs. M1
polarization significantly reduced basal and maximal OCR in
WT-BMDMs; however, the OCR in LPS+ IFN-γ treated PDK2/4
DKO-BMDMs was still comparable to that in WT-BMDMs (M0)
(Figure 1H). Likewise, DCA treatment was found to largely
prevent the reduction in basal and maximal OCR in LPS + IFN-
γ-treated WT-BMDMs, which are known, otherwise, to have a
broken TCA cycle (evidenced by the accumulation of succinate)
during M1 polarization (Figure 1I) (19). Elevated extracellular
lactate and intracellular succinate levels were also significantly
attenuated in PDK2/4 DKO-BMDMs compared to that in WT-
BMDMs (Figures S2A,B). Overall, our data are indicative that
genetic as well as pharmacological inhibition of PDK2/4 can
block the metabolic reprogramming of aerobic glycolysis and
mitochondrial respiration under conditions that normally induce
M1 macrophage polarization.
PDK2/4 Deficiency Prevents the Increase
in Glycolytic Intermediates and the
Decrease in TCA Cycle Intermediates
Normally Induced by Treating
Macrophages With Inflammatory Stimuli
Based on our finding that mitochondrial respiration is enhanced
when M1 polarization is prevented by PDK2/4-deficiency,
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FIGURE 1 | PDK2 and PDK4 are required for M1 macrophage polarization. (A) Heat map for relative mRNA levels of PDK isoforms measured by qRT-PCR. eWAT
refers to epididymal AT from WT mice fed an HFD in comparison to epididymal AT from WT mice fed a CD for 24 weeks. M1 refers to PM stimulated for 24 h with LPS
100 ng/mL+ IFN-γ 10 ng/mL relative to unstimulated PM. M2 refers to PM stimulated for 24 h with IL-4 10 ng/mL+ IL-10 10 ng/mL relative to unstimulated PMs.
n = 5–7 per group for AT and n = 3 per group for PMs. Values are expressed as mean ± SD for PMs and ± SEM for AT. Statistical analysis was performed by
Student’s t-test. *p < 0.05 vs. control. (B) PDK expression levels were assessed in PMs after M1 stimulation with LPS 100 ng/mL+ IFN-γ 10 ng/mL for the indicated
times. (C) M1 and M2 markers in PMs prepared from WT, PDK2 KO, PDK4 KO, and PDK2/4 DKO mice followed by M1 stimulation with LPS 100 ng/mL+ IFN-γ
10 ng/mL or M2 stimulation with IL-4 10 ng/mL+ IL-10 10 ng/mL for 12 h. (D) The expressions of PDK isozymes in PMs from WT and DKO mice. (E) Volcano plots for
the comparisons of M1-WT vs. Cont-WT (upper) and M1-DKO vs. M1-WT (lower). Dotted lines represent the cutoffs for fold change and p-value. Red and green dots
denote up- and down-regulated genes, respectively. (F) Heat map of genes involved in glycolysis and TCA cycle. The color bar represents the gradient of log2 (fold
change) of mRNA expression levels in each comparison. The genes that were up- (down-) regulated in M1-WT compared to Cont-WT and down- (up-) regulated in
M1-DKO compared to M1-WT at the same time were indicated by an asterisk. (G) GOBPs represented by the genes that were up-regulated in M1-WT compared to
Cont-WT and down-regulated in M1-DKO compared to M1-WT at the same time. The p-value is the significance of GOBPs being enriched by the genes. (H,I) OCRs
were measured in WT- or DKO-BMDM in the presence or absence of M1 stimulation by LPS (100 ng/mL) + IFN- γ (10 ng/mL) treatment for 3 h (H) and DCA (10mM)
treatment (I); n = 4–5 per group. Values are expressed as mean ± SD. Statistical analysis was performed by Student’s t-test. *p < 0.05 vs. (–) M1 stimulation,
†
p <
0.05 vs. control-WT, and #p < 0.05 vs. M1-WT.
we hypothesized that acetyl-CoA (generated by conversion of
pyruvate to acetyl-CoA by PDH) might be utilized efficiently
by the intermediates of TCA cycle, resulting in increased
OXPHOS with less lactate production. To test our hypothesis,
we performed 13C6-glucose trace analysis (a schematic
representation of metabolite labeling with 13C6-glucose is
given in Figure 2A) and assessed the relative mass distribution
vector represented by the metabolites derived from 13C6-glucose
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directly, as well as the total amount of metabolites from glucose
metabolism during PDK2/4 deficiency (Figures 2B,C) (20).
As assessed by two different methods and consistent with the
altered expression of glycolytic enzymes (Figure 1F), the steady
state amounts of metabolites between glucose to lactate were
significantly increased in M1-polarized WT-PMs, while PDK2/4
deficiency was found to prevent increases in these intermediates
(Figure 2B, Figure S2C). Although the mass of citrate was not
significantly affected, formation of M+2 citrate (blue in the
pie chart) from M+6 glucose was reduced in M1-polarized
WT-PM but increased by PDK2/4 deficiency, consistent with
decreased flux in the former and increased flux in the latter
(Figure 2C). Although total amounts of succinate and malate
were significantly increased, M+2 succinate and M+2 malate
levels (blue in the pie chart) were significantly reduced in
M1-polarized WT-PM. Interestingly, metabolic flux analysis
of these intermediates displayed enhanced enrichments in
PDK2/4-deficient conditions (Figure 2C; Figures S2D,E). These
data suggest that increased provision of acetyl-CoA for the
maintenance of the TCA cycle by PDK2/4 deficiency prevents
the decrease in cellular respiration characteristic of M1-polarized
WT macrophages.
Global PDK 2/4 Deficiency in HFD-Fed
Mice Reduces Insulin Resistance and AT
Inflammation
Greater PDH activity caused by global PDK 2/4 deficiency
improves insulin sensitivity (15), suggesting PDKs are involved
in the development of whole-body insulin resistance. To
determine whether DKO mice show reduced HFD-induced AT
inflammation which may contribute to the healthier metabolic
phenotype of these mice, WT and DKO mice were fed
CD or HFD. As reported previously (15), HFD-fed-PDK2/4
ablated mice displayed lower body weight gain, lower fasting
blood glucose levels, improved glucose tolerance, and increased
insulin sensitivity along with reduced fat accumulation in
the AT and liver (Figures 3A–E). Furthermore, the number
of infiltrated epididymal AT macrophages was reduced, as
indicated by reduction in crown-like structures and the levels
of proinflammatory markers Emr1, Cd68, Itgax, and Tnf
(Figures 3F–H). These data show that global PDK2/4 deficiency
attenuates HFD-induced macrophage infiltration and thereby
reduces AT inflammation, suggesting that inhibition of PDH
activity by the PDKs is involved in the AT inflammation caused
by obesity.
Bone Marrow-Specific PDK2/4 Deletion
Interferes With HFD-Induced AT
Macrophage Infiltration
To investigate the potential effects of innate immune cells on
chronic inflammation, a bone-marrow (BM) transplantation
mouse model was used to evaluate the direct contribution of
BM-derived immune cells from PDK2/4 DKOmice. The method
involved irradiation of recipient WT mice to ablate BM cells
followed by transplantation via intravenous infusion of donor
BM obtained from WT mice or PDK2/4 DKO mice (21); donor
as well as recipient mice were maintained on a CD for this
study. Four weeks after maintaining all of the mice on a CD,
the mice were divided into four groups: 1) WT mice with WT
BM that were continued on the CD; 2) WT mice with WT BM
that were placed on the HFD; 3) WT mice with DKO BM that
were continued on the CD; and 4) WT mice with DKO BM
that were placed on the HFD. No differences in any subsequent
measurements were observed between the two groups of mice
(1 and 3) that were continued on the CD (Figure 4). Likewise,
no differences in body weight, body size, and food consumption
were observed between the two groups of mice (2 and 4)
that were maintained on the HFD (Figures 4A–C). However,
remarkable differences in markers of metabolic dysfunction were
observed between the latter two groups of mice. The HFD-fed
mice transplanted with WT-BM displayed an increase in fasting
blood glucose, AT, and liver fat, while the glucose tolerance
and insulin sensitivity was found to be reduced. All of these
expected negative consequences of HFD feeding were attenuated
in mice transplanted with DKO-BM (Figures 4D–H). These
findings along with reduced inflammatory responses and no
additional anti-inflammatory cytokine production such as IL-
10 and TGF-β by PDK2/4 deficiency under sterile inflammatory
condition (Figure 5 and Figure S3) are consistent with other
reports that have demonstrated improved insulin sensitivity in
response to global PDK 2/4 deficiency and, consequently, greater
PDH activity (22).
Furthermore, the number of crown-like structures was
dramatically increased in the AT of mice with WT BM but
not in the mice with DKO-BM (Figures 6A,B). To confirm
the reduced migrating capacity of PDK2/4 ablated monocyte to
fat tissue in vivo, we assessed that the PKH26-positive stained
macrophage (F4/80+CD11b+PKH26+) population derived from
DKOmonocyte was significantly reduced in the stromal vascular
fractions of 4 week HFD mice compared to WT monocyte
(Figure 6C). Pharmacological inhibition of PDK activity with
DCA was found to significantly attenuate MCP-1-induced
migration (Figure 6D). To mimic the in vivo physiological effect
of HFD, BMDMswere incubated with palmitate-treated, 3T3-L1-
conditioned medium. Interestingly, DCA treatment was found
to significantly reduce the migration induced by an unknown
chemoattractant in palmitate-treated 3T3-L1 cells (Figure 6E).
We also confirmed that the increase in M1/M2 ratio as well as
levels of proinflammatory markers was significantly blocked in
the epididymal AT from WT mice with DKO-BM (Figures 6F,G
and Figure S4). These results are indicative that PDK2/4 deletion
and PDK inhibition prevent macrophage polarization and
infiltration, thereby preventing inflammation of adipose tissue in
response to over consumption of dietary energy.
A Novel PDK Inhibitor Prevents
Polarization of Macrophages to the M1
Phenotype and Attenuates Adipose Tissue
Inflammation in Obesity
We used a series of previously established, highly specific
PDK inhibitors that target structurally conserved ATP-
binding pockets in the PDKs (23, 24) to perform an efficacy
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FIGURE 2 | PDK2/4 deletion increases glucose oxidation by macrophages. (A) Schematic representation of metabolite labeling by 13C6-glucose. The relative
amounts of metabolites are represented by the pie charts and the different colors indicate labeling with different mass isotopomers. (B,C) The relative amounts and
13C enrichment patterns of the intermediates of the glycolytic (B) and TCA cycle (C) in WT- and DKO-PMs compared with control-WT; n = 4–5 per group. Values are
expressed as mean ± standard error of mean (SEM). Statistical analysis was performed by Student’s t test. *p < 0.05 vs. (-) M1 stimulation,
†
p < 0.05 vs. control-WT,
and # p < 0.05 vs. M1-WT.
test against the inflammatory response (Figures S5A–C).
In contrast to the high DCA concentrations (0.5∼2mM)
required for the inhibition of PDKs, a novel PDK inhibitor,
KPLH1130, was found to significantly inhibit expression
of proinflammatory cytokines including TNFα, IL-6, and
IL-1β in various types of macrophages at much lower (5–
10µM) concentrations (Figures 7A–D, 8A–E; Figures S5D–F).
In addition to reduced migration capacity by KPLH1130
treatment, iNOS, nitric oxide, and HIF-1α levels were
significantly reduced by pharmacological PDK inhibition
in various types of macrophages (Figures 7E–G, 8F–H;
Figures S5G–M). KPLH1130 also prevented the decrease in
basal and maximal OCR caused by M1 polarizing conditions
in BMDMs (Figure 7H). We also found that KPLH1130
administration improved the glucose tolerance of HFD-fed
mice (Figure 7I). Similarly, these effects were not mediated
by induced anti-inflammtory cytokines (Figures 8I–K). Taken
together, our results are indicative that KPLH1130 can effectively
Frontiers in Immunology | www.frontiersin.org 6 May 2019 | Volume 10 | Article 944
Min et al. PDK Inhibition Improves Insulin Resistance
FIGURE 3 | PDK2/4 deficiency ameliorates adipose tissue inflammation and insulin resistance in mice fed a high fat diet. (A–D) Measurements of body weights (A),
fasting blood glucose levels (B), glucose tolerance test (1.5 g/kg, i.p.) after 16 h fasting (C) and insulin tolerance test (0.75 U/kg, i.p.) after 6 h fasting (D) were
performed in CD or HFD-fed mice; n = 8–14 per group. (E) Representative morphology of the subcutaneous AT and liver from mice fed CD or HFD for 24 weeks, as
shown by H&E staining; magnification: 400X; scale bar: 20µm. (F,G) Representative morphology of the epididymal AT, as shown by H&E staining or IHC staining for
F4/80; magnification: 400X; scale bar: 20µm (F). Quantification of crown-like structures in the epididymal AT; n = 6–9 per group (G). (H) mRNA expression levels of
inflammatory genes in the epididymal AT; n = 7–12 per group. Values are expressed as mean ± SEM. Statistical analysis was performed by Student’s t-test. *p < 0.05
vs. CD-WT, and #p < 0.05 vs. HFD-WT.
attenuate inflammatory responses induced by obesity-associated
metabolic dysfunction.
DISCUSSION
This study shows that PDK2/4 deficiency blocks polarization
of resting macrophages to the M1 phenotype in response to
LPS and INF-γ. Our findings establish that the regulation
of PDH activity by the PDKs plays an important role in
M1 macrophage polarization. The evidence for this includes
a) dramatically induced PDK4 expression by LPS + INF-γ;
b) reduced HIF-1α levels and suppression of the Warburg
effect (phenomenon characterized by upregulation of glycolytic
enzymes and down regulation of TCA cycle enzymes) in
response to PDK2/4 deficiency; c) PDK2/4 deficiency-mediated
check on the pool size of glycolytic intermediates that would,
otherwise, feed into anabolic pathways required for proliferation
of macrophages; and d) significantly reduced levels of NO and
proinflammatory cytokines including TNFα, IL-6, and IL-1β in
response to PDK2/4 deficiency. These findings suggest that sterile
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FIGURE 4 | Hematopoietic cell-specific PDK2/4 deficiency attenuates insulin resistance in mice fed a high-fat diet. (A) Body weights were measured during feeding of
the different diets; n = 12–26 per group. (B) Representative mice of each group (C) Food consumption was measured per day in each group; n = 7 per group.
(D–G) Measurement of fasting blood glucose levels (D), glucose tolerance test (1.5 g/kg, i.p.) after 16 h fasting (E,F), and insulin tolerance test (0.75 U/kg, i.p.) after
6 h fasting (G) was performed in both CD and HFD-fed mice; n = 11–26 per group. Values are expressed as mean ± SEM. Statistical analysis was performed by
one-way or two-way ANOVA followed by Tukey’s HSD. # p < 0.05 vs. HFD-WT-BMT. (H) Representative morphology of the subcutaneous AT and liver from WT- and
DKO-BMT mice as shown by H&E staining; magnification: 400X; scale bar: 20µm.
inflammatory conditions, such as neuroinflammatory diseases,
obesity, and steatohepatitis may be amendable to therapeutic
intervention with PDK inhibitors.
Markers of AT inflammation including the number of
infiltrated AT macrophages in response to over-nutrition, M1
macrophage population, presence of crown-like structures, and
the levels of proinflammatory markers were found to be
significantly reduced in the global PDK2/4 DKO mice compared
to that in WT mice. These indicators of AT inflammation
are associated with the metabolic dysfunctions characteristic
of obesity including hyperglycemia, glucose intolerance, and
insulin resistance. These findings clearly establish an important
role for PDKs and, therefore, the regulation of the activity of
the PDH complex in obesity-induced AT inflammation and
metabolic dysfunction. To directly determine if these effects
could be due to prevention of M1 macrophage polarization
by PDK deficiency, macrophage-specific PDK deficiency was
induced by transplanting PDK2/4-deficient myeloid cells into
irradiated WT mice that were subsequently fed an HFD to
induce obesity. Whereas, the AT of obese mice transplanted
with normal myeloid cells became inflamed as evidenced by the
accumulation of crown-like structures and protein markers for
M1 macrophages, the AT of mice transplanted with PDK2/4-
deficient cells remained free of inflammation; additionally, the
negative effects on blood glucose levels, glucose tolerance, and
insulin sensitivity were partially ablated. The observation that
glucose tolerance and insulin sensitivity in HFD-fed DKO-BMT
mice is only partially improved in contrast to the almost complete
protection from HFD-induced glucose intolerance, insulin
insensitivity, obesity, andmacrophage infiltration observed in the
organs of PDK2/4 DKO mice is suggestive that the beneficial
effects of PDK deficiency are not totally due to inhibition
of macrophage polarization. In other words, increased PDH
activity in tissue other than myeloid cells plays a role in
the beneficial effects of global PDK2/4 deficiency in HFD-
fed mice.
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FIGURE 5 | Suppression of PDK2/4 in macrophages attenuates the secretion of proinflammatory effectors in response to inflammatory stimuli. (A–E) The levels of
mRNA expression (A) and secreted proinflammatory effectors (B–E) were measured after treatment of WT- and DKO-PMs or -BMDMs with LPS 100 ng/mL+ IFN- γ
10 ng/mL for 12 h; n = 3–4 per group. (F) Bactericidal effect was assessed by counting the colony numbers in WT- and DKO-PMs; n = 5 per group. (G) Effect on
PDK2/4 deficiency on the in vivo macrophage population in LPS (1 mg/kg)-injected mice; n = 5 per group. Values are expressed as mean ± SEM. Statistical analysis
was performed using Student’s t-test. #p < 0.05 vs. WT. (H–K) Secreted proinflammatory cytokine levels were determined at different DCA concentrations in THP1
cells treated with LPS 100 ng/mL for 24 h; n = 3 per group. (L) Adhesion assay was performed in collagen (10µg/mL)-coated wells with DCA-treated THP-1 cells
incubated with LPS (300 ng/mL) for 24 h; n = 3 per group. Values are expressed as mean ± SD. Statistical analysis was performed using Student’s t-test. *p < 0.05
vs. (–) LPS, #p < 0.05 vs. only LPS, and
†
p < 0.05 vs. 2mM DCA. N.D, not detected.
The present study also shows that KPLH1130, a novel
PDK-specific inhibitor, blocks M1 polarization and attenuates
proinflammatory responses. Additionally, we have observed that
M2-polarized PDK2/4 DKOmacrophages express elevated levels
of arginase-1—a superior competitor to iNOS for the substrate
arginine—which has anti-inflammatory functions. Themetabolic
activation of macrophages triggered by glucose, insulin, and
palmitate plays a key role in adipose-driven inflammation
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FIGURE 6 | Hematopoietic cell-specific PDK2/4 deficiency attenuates adipose tissue inflammation by preventing the recruitment of M1 macrophages. (A,B)
Representative morphology of the epididymal AT by H&E staining or IHC staining for F4/80; magnification: 400X; scale bar: 20µm (A). The numbers of crown-like
structures in the epididymal AT were determined; n = 8 per group (B). Values are expressed as mean ± SEM. Statistical analysis was performed by one-way ANOVA
followed by Tukey’s HSD. #p < 0.05 vs. HFD-WT-BMT. (C) PKH26+ cell population was measured by FACS analysis; n = 4 per group. Values are expressed as mean
± SEM. Statistical analysis was performed by Student’s t-test. #p < 0.05 vs. WT monocyte donor group. (D) MCP-1-induced migration was evaluated in DCA-treated
BMDMs using a trans-well migration assay; n = 3 per group; magnification: 200X; scale bar: 50µm. The relative number of migrated cells per field was counted.
Values are expressed as mean ± SEM. Statistical analysis was performed by Student’s t-test. *p < 0.05 vs. control, #p < 0.05 vs. MCP-1 induction.
(E) 3T3-L1-conditioned medium (C.M.)-induced migration was evaluated in DCA-treated BMDMs using a trans-well migration assay; n = 3 per group; magnification:
200X; scale bar: 50µm. The relative number of migrated cells per field was counted. Values are expressed as mean ± SEM. Statistical analysis was performed by
Student’s t-test. *p < 0.05 vs. control, #p < 0.05 vs. palmitate C.M. (F) M1 and M2 macrophage populations and their ratios were determined in the stromal vascular
fraction of WT- and DKO-BMT; n = 3 per group. Values are expressed as mean ± SEM. Statistical analysis was performed by Student’s t-test. *p < 0.05 vs.
corresponding CD-fed group, # p < 0.05 compared with WT- and DKO-BM donor group. (G) mRNA expression levels of inflammatory genes in the epididymal AT;
n = 7–12 per group. Values are expressed as mean ± SEM. Statistical analysis was performed by Student’s t-test. *p < 0.05 vs. CD, #p < 0.05 vs. WT-BMT.
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FIGURE 7 | A new PDK inhibitor, KPLH1130, attenuates the secretion of pro-inflammatory effectors by stimulated macrophages and improves glucose tolerance in
HFD-fed mice. (A–F) The levels of mRNA expression (A,E) and secreted proinflammatory effectors (B–D,F) were measured with different KPLH1130 concentrations in
PMs treated for 12 h with LPS (100 ng/mL) + IFN-γ (10 ng/mL); n = 3–6 per group. (G) M1 markers were assessed with different KPLH1130 concentrations in PMs
treated with LPS (100 ng/mL) + IFN-γ (10 ng/mL) for 12 h. (H) OCRs were measured in KPLH1130 (10µM) ± M1 stimulation by LPS (100 ng/mL) + IFN-γ (10 ng/mL)
for 3 h; n = 4–5 per group. Values are expressed as mean ± SD. Statistical analysis was performed by Student’s t-test. *p < 0.05 vs. control, #p < 0.05 vs. M1 only,
and
†
p < 0.05 vs. KPLH1130 (10µM). (I) Glucose tolerance test (1.5 g/kg, i.p.) after 6 h fasting was measured after HFD for 14 weeks with KPLH1130 (70 mg/kg, 4
weeks); n = 6 per group. Values are expressed as mean ± SEM. Statistical analysis was performed by one-way followed by Tukey’s HSD. *p < 0.05 vs. vehicle control.
which results in insulin resistance—a process distinct from
classical activation (25). Both genetic and pharmacological
inhibition of PDK in macrophages significantly suppressed
proinflammatory responses including M1 polarization markers,
bactericidal activity, adherence, and migration. These findings
support the notion that PDKs are potential targets for the
treatment of inflammation as well as the negative metabolic
repercussions of inflammatory conditions.
Gene set enrichment analysis identified the signaling pathways
associated with inflammatory responses. Interestingly, the
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FIGURE 8 | Macrophage activation is suppressed by the novel PDK inhibitor, KPLH1130 using Zymosan-elicited PMs and LPS-elicited PMs. (A–G) mRNA expression
(A,B,F) and secreted proinflammatory effectors (C–E,G) were measured following KPLH1130 (10µM) treatment of ZEPMs or LEPMs incubated with LPS (100 ng/mL)
+ IFN-γ (10 ng/mL) for 12 h; n = 3 per group. (H) M1 markers were assessed following KPLH1130 (10µM) treatment of ZEPMs incubated with LPS (100 ng/mL) +
IFN-γ (10 ng/mL) for 12 h. (I–J) mRNA expression of IL-10 and TGFβ (I) and secreted IL-10 (J) and TGFβ (K) were measured following KPLH1130 (10µM) treatment
of ZEPMs and BMDMs, respectively incubated with LPS (100 ng/mL) + IFN-γ (10 ng/mL) for 12 h; n = 3 per group. Values are expressed as mean ± SD. Statistical
analysis was performed using Student’s t-test. *p < 0.05 vs. control, #p < 0.05 vs. M1+V.C and
†
p < 0.05 vs. different doses of KPLH1130.
decrease in Idh expression, indicating a metabolic break in the
TCA cycle of M1-polarized macrophages (26), was significantly
attenuated after PDK2/4 deletion. PDK2/4 deletion prevented the
reduction in mitochondrial OXPHOS that normally occurs in
response to M1 stimulation. A metabolic switch from OXPHOS
to aerobic glycolysis is followed by increased production of
lactate and the accumulation of citrate and succinate by TLR4
activation (27, 28). According to our stable isotope flux study,
PDK 2/4 ablation prevented the metabolic breaks associated
with citrate and succinate accumulation as well as the increased
lactate production in M1-polarized macrophages. In the case of
PDK2 deficiency in hepatocytes, 13C-glucose tracer analysis has
suggested that PDC flux increases but TCA cycle intermediate
flux decreases due to shunted ketogenesis (29).
Although the same effects induced by PDK2/4 deficiency on
macrophage polarization are also induced by PDK1 deficiency
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(9), PDK1 is not sensitive to induction by LPS stimulation (13),
and PDK1 deficiency is less effective in preventing the expression
of the glycolytic enzymes (9). Nevertheless, the finding that
deficiencies of PDK1 and PDK2/4 blockmacrophage polarization
to the proinflammatory phenotype indicates that reducing
PDH activity by phosphorylation is required for LPS-induced
macrophage polarization. Surprisingly, it has been reported that
LPS-induced macrophage polarization is also prevented by a
number of manipulations that strongly inhibit PDH flux. These
include knockdown of pyruvate dehydrogenase phosphatase 1
(12), pharmacological inhibition of pyruvate import into the
mitochondria (13), and upregulation of PDK2 by VSIG4 (14).
These findings suggest that complete inhibition of PDH is
not compatible with proinflammatory macrophage polarization.
Indeed, pyruvate oxidation through PDH is necessary for
the synthesis of the antimicrobial metabolite itaconate, an
important product of mature proinflammatory macrophages
(13). The finding that macrophage polarization is prevented
by both inhibition of PDH and PDK deficiency suggests
that LPS-induced polarization of macrophages is extremely
sensitive to PDH flux. This is consistent with the evidence
that reprogramming of the mitochondrial processes, particularly
glutaminolysis, is also necessary for the inflammatory responses
of M1 macrophages (30). If flux through PDH is too high
or too low, changes in gene expression, reprogramming of
glycolysis and the TCA cycle, and polarization to the M1
phenotype are prevented. Perhaps changes in the levels of
metabolites transmit information to the nucleus when conditions
are right for the reprogramming of gene expression necessary
for polarization. The location of PDH allows it to precisely
control the relationship between glycolysis and the TCA cycle
and therefore serves as a sensitive checkpoint of bioenergetic
reprogramming. In spite of the complexity, this makes PDH
a sensitive target for therapeutic intervention in inflammatory
conditions, suggesting that PDK2 and PDK4 in immune
cells are potential targets for the treatment of inflammatory
metabolic disorders.
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